What is the role of vibratory counterstimulation (Relaxis) in the treatment of restless legs syndrome (RLS)?

Updated: Feb 22, 2017
  • Author: Ali M Bozorg, MD; Chief Editor: Selim R Benbadis, MD  more...
  • Print
Answer

In 2014, the US Food and Drug Administration (FDA) gave commercial clearance to the first device (Relaxis) for improvement of sleep quality in patients with primary RLS. The device, a vibrating pad, delivers vibratory counterstimulation to the patient’s legs as an individual lies in bed. Approval was based on 2 randomized studies that showed greater improvements in sleep quality with the device than with a placebo pad. [26]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!